Shockwave Medical (NASDAQ:SWAV) PT Raised to $275.00 at Wells Fargo & Company

Shockwave Medical (NASDAQ:SWAV – Get Rating) had its price target raised by Wells Fargo & Company from $252.00 to $275.00 in a report issued on Tuesday morning, The Fly reports. SWAV has been the topic of several other research reports. Bank of America lifted their price objective on Shockwave Medical from $235.00 to $275.00 and […]

Related Keywords

United States ,America ,Douglas Evan Godshall ,Piper Sandler ,Trinh Phung ,Canaccord Genuity Group ,Securities Exchange Commission ,Ameritas Advisory Services ,Needham Company ,Global Retirement Partners ,International Assets Investment Management ,Anfield Capital Management ,Wells Fargo Company ,Shockwave Medical Inc ,Shockwave Medical ,Get Rating ,Wells Fargo ,Genuity Group ,Moderate Buy ,Evan Godshall ,Exchange Commission ,Assets Investment Management ,Retirement Partners ,Advisory Services ,Shockwave Medical Daily ,Nasdaq Swav ,Swav ,Medical ,Boost Price Target ,